Doxycycline ameliorates the severity of experimental proliferative vitreoretinopathy in mice

Shun Hua Chen, Yu Jheng Lin, Li Chiu Wang, Hsien Yang Tsai, Chang Hao Yang, Yu Ti Teng, Sheng Min Hsu

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


After successful surgeries for patients with rhegmatogenous retinal detachment, the most common cause of retinal redetachment is proliferative vitreoretinopathy (PVR), which causes severe vision impairment and even blindness worldwide. Until now, the major treatment for PVR is surgical removal of the epiretinal membrane, while effective treatment to prevent PVR is still unavailable. Therefore, we investigated the potential of doxycycline, an antibiotic in the tetracycline class, to treat PVR using a mouse model. We used the human retinal pigment epithelial cell line, ARPE-19, for in vitro and in vivo studies to test doxycycline for PVR treatment. We found that doxycycline suppressed the migration, proliferation, and contraction of ARPE-19 cells with reduced p38 MAPK activation and total MMP activity. Intravitreal doxycycline and topical tetracycline treatment significantly ameliorated the PVR severity induced by ARPE-19 cells in mice. PVR increased the expression of MMP-9 and IL-4 and p38 MAPK phosphorylation and modestly decreased IL-10. These effects were reversed by doxycycline and tetracycline treatment in the mouse retina. These results suggest that doxycycline will be a potential treatment for PVR in the future.

Original languageEnglish
Article number11670
JournalInternational journal of molecular sciences
Issue number21
Publication statusPublished - 2021 Nov 1

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry


Dive into the research topics of 'Doxycycline ameliorates the severity of experimental proliferative vitreoretinopathy in mice'. Together they form a unique fingerprint.

Cite this